{"id":"https://openalex.org/W2396891752","doi":null,"title":"Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.","display_name":"Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.","publication_year":1999,"publication_date":"1999-08-01","ids":{"openalex":"https://openalex.org/W2396891752","mag":"2396891752","pmid":"https://pubmed.ncbi.nlm.nih.gov/10780263"},"language":"en","primary_location":{"id":"pmid:10780263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10780263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"E Lessard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Lessard","raw_affiliation_strings":["Quebec Heart Institute, Laval Hospital, Ste-Foy, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital, Ste-Foy, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016297281","display_name":"Marie\u2010Andr\u00e9e Yessine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Yessine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111775601","display_name":"Bettina A. Hamelin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B A Hamelin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011647323","display_name":"Gilles E O\u2019Hara","orcid":"https://orcid.org/0000-0002-1115-8108","observed_orcids":["https://orcid.org/0000-0002-1115-8108"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G O'Hara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069797338","display_name":"Jacynthe LeBlanc","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J LeBlanc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080359453","display_name":"Jacques Turgeon","orcid":"https://orcid.org/0000-0002-7978-9280","observed_orcids":["https://orcid.org/0000-0002-7978-9280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Turgeon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.6817,"has_fulltext":false,"cited_by_count":175,"citation_normalized_percentile":{"value":0.95967938,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"4","first_page":"435","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cyp2d6-polymorphism","display_name":"CYP2D6 polymorphism","score":0.8949999809265137},{"id":"https://openalex.org/keywords/quinidine","display_name":"quinidine","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6629999876022339},{"id":"https://openalex.org/keywords/o-desmethylvenlafaxine","display_name":"O-desmethylvenlafaxine","score":0.9020000100135803},{"id":"https://openalex.org/keywords/venlafaxine-hydrochloride","display_name":"venlafaxine hydrochloride","score":0.7440000176429749},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6269999742507935},{"id":"https://openalex.org/keywords/poor-metabolizers","display_name":"poor metabolizers","score":0.6309999823570251},{"id":"https://openalex.org/keywords/extensive-metabolizers","display_name":"extensive metabolizers","score":0.8309999704360962},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.656000018119812},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6959999799728394},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8634383678436279},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.8557802438735962},{"id":"https://openalex.org/C2780339425","wikidata":"https://www.wikidata.org/wiki/Q412496","display_name":"Quinidine","level":2,"score":0.8249925374984741},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7418886423110962},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.6009213328361511},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5533313155174255},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.512628972530365},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.5118769407272339},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48440057039260864},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.47385528683662415},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4082998037338257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3318401575088501},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2985365390777588},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29477810859680176},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.2851281464099884},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.22766563296318054},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09006431698799133},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.08582594990730286},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10780263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10780263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Clinical Trial"},{"id":"mag:2396891752","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10780263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2231133613","https://openalex.org/W1992320105","https://openalex.org/W2023765120","https://openalex.org/W2084497711","https://openalex.org/W2385816900","https://openalex.org/W2002050650","https://openalex.org/W7155055594","https://openalex.org/W3149507942","https://openalex.org/W2167690131","https://openalex.org/W1488321941"],"abstract_inverted_index":{"According":[0],"to":[1,139,149,156,181,222,225,236,245,273],"in-vitro":[2],"studies":[3],"with":[4,14,59,65,284,294],"microsomes":[5],"from":[6,10,176,240],"human":[7],"livers":[8],"and":[9,39,63,91,106,205,224,267],"yeast":[11],"expression":[12],"systems":[13],"high":[15],"CYP2D6":[16,37,278,303],"activity,":[17],"the":[18,33,36,40,51,60,66,94,125,161,165,217,295],"major":[19,307],"oxidation":[20],"pathway":[21],"of":[22,35,42,53,97,128,153,164,220,257,271,309],"venlafaxine":[23,72,121,129,173,203,211,221,272,310],"is":[24],"catalysed":[25],"by":[26,229],"CYP2D6.":[27],"In":[28,168,214,253],"this":[29],"study,":[30],"we":[31],"investigated":[32],"role":[34],"polymorphism":[38],"effects":[41,194],"low-dose":[43],"quinidine,":[44],"a":[45,150,306],"selective":[46],"inhibitor":[47],"of,":[48],"CYP2D6,":[49],"on":[50,83,195],"disposition":[52,311],"venlafaxine.":[54],"Fourteen":[55],"healthy":[56],"men,":[57],"eight":[58],"extensive":[61,140,169],"metabolizer":[62,68],"six":[64],"poor":[67,136,154,254],"phenotype":[69],"were":[70,109],"administered":[71,123],"hydrochloride":[73],"18.75":[74],"mg":[75,101],"orally":[76],"every":[77,102],"12":[78,103],"h":[79,82],"for":[80],"48":[81],"two":[84],"occasions":[85],"(1":[86],"week":[87],"apart);":[88],"once":[89,92],"alone":[90,204],"during":[93,202,210,292],"concomitant":[95],"administration":[96],"quinidine":[98,171,230,258],"sulfate":[99],"100":[100,177],"h.":[104],"Blood":[105],"urine":[107],"samples":[108],"collected":[110],"under":[111],"steady-state":[112],"conditions":[113],"over":[114],"one":[115],"dosing":[116],"interval":[117],"(12":[118],"h).":[119],"When":[120],"was":[122,130,146,227],"alone,":[124],"oral":[126,174,265],"clearance":[127,175,197,266],"more":[131],"than":[132],"fourfold":[133],"less":[134],"in":[135,264,289,312],"metabolizers":[137,141,155],"compared":[138],"(P":[142,250],"<":[143,190,251],"0.05).":[144,252],"This":[145],"mainly":[147],"due":[148],"decreased":[151,172,239],"capability":[152],"form":[157],"O-desmethylated":[158,237],"metabolites":[159,238],"at":[160],"position":[162],"4":[163,206],"aromatic":[166],"moiety.":[167],"metabolizers,":[170,255],"+/-":[178,183,187,199,207,242,247],"62":[179],"l/h":[180,185,201,209,244,249],"17":[182],"5":[184],"(mean":[186],"SD;":[188],"P":[189],"0.05)":[191],"without":[192],"any":[193],"renal":[196],"(4":[198],"1":[200,208,248],"plus":[212],"quinidine).":[213],"these":[215],"individuals,":[216],"sequential":[218],"metabolism":[219],"O-desmethylvenlafaxine":[223],"N,O-didesmethylvenlafaxine":[226],"inhibited":[228],"coadministration":[231,256],"so":[232],"that":[233],"metabolic":[234,269],"clearances":[235,270],"43":[241],"32":[243],"2":[246],"did":[259],"not":[260],"cause":[261],"significant":[262],"changes":[263],"partial":[268],"its":[274],"various":[275],"metabolites.":[276],"Decreased":[277],"activity":[279,304],"could":[280],"also":[281],"be":[282],"associated":[283],"cardiovascular":[285],"toxicity":[286],"as":[287],"observed":[288],"four":[290],"patients":[291],"treatment":[293],"drug.":[296],"Thus,":[297],"genetically":[298],"determined":[299],"or":[300],"pharmacologically":[301],"altered":[302],"represents":[305],"determinant":[308],"humans.":[313]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}